Skip to main content
Erschienen in: Drug Safety 3/2005

01.03.2005 | Original Research Article

Identification of Priorities for Medication Safety in Neonatal Intensive Care

verfasst von: Desireé L. Kunac, David M. Reith

Erschienen in: Drug Safety | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

Background: Although neonates are reported to be at greater risk of medication error than infants and older children, little is known about the causes and characteristics of error in this patient group. Failure mode and effects analysis (FMEA) is a technique used in industry to evaluate system safety and identify potential hazards in advance. The aim of this study was to identify and prioritise potential failures in the neonatal intensive care unit (NICU) medication use process through application of FMEA.
Methods: Using the FMEA framework and a systems-based approach, an eight-member multidisciplinary panel worked as a team to create a flow diagram of the neonatal unit medication use process. Then by brainstorming, the panel identified all potential failures, their causes and their effects at each step in the process. Each panel member independently rated failures based on occurrence, severity and likelihood of detection to allow calculation of a risk priority score (RPS).
Results: The panel identified 72 failures, with 193 associated causes and effects. Vulnerabilities were found to be distributed across the entire process, but multiple failures and associated causes were possible when prescribing the medication and when preparing the drug for administration. The top ranking issue was a perceived lack of awareness of medication safety issues (RPS score 273), due to a lack of medication safety training. The next highest ranking issues were found to occur at the administration stage. Common potential failures related to errors in the dose, timing of administration, infusion pump settings and route of administration. Perceived causes were multiple, but were largely associated with unsafe systems for medication preparation and storage in the unit, variable staff skill level and lack of computerised technology.
Conclusion: Interventions to decrease medication-related adverse events in the NICU should aim to increase staff awareness of medication safety issues and focus on medication administration processes.
Literatur
2.
Zurück zum Zitat Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324(6): 377–84PubMedCrossRef Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324(6): 377–84PubMedCrossRef
3.
Zurück zum Zitat Wilson RM, Runciman WB, Gibberd RW, et al. The quality in Australian health care study. Med J Aust 1995; 163(9): 458–71PubMed Wilson RM, Runciman WB, Gibberd RW, et al. The quality in Australian health care study. Med J Aust 1995; 163(9): 458–71PubMed
4.
Zurück zum Zitat Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals: principal findings from a national survey. Occasional Paper No. 3. Wellington: Ministry of Health [online]. Available from URL: http://www.moh.govt.nz/moh.nsf [Accessed 2004 Jan 23] Davis P, Lay-Yee R, Briant R, et al. Adverse events in New Zealand public hospitals: principal findings from a national survey. Occasional Paper No. 3. Wellington: Ministry of Health [online]. Available from URL: http://​www.​moh.​govt.​nz/​moh.​nsf [Accessed 2004 Jan 23]
6.
Zurück zum Zitat Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322(7285): 517–9PubMedCrossRef Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ 2001; 322(7285): 517–9PubMedCrossRef
7.
Zurück zum Zitat Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA 1997; 277(4): 307–11PubMedCrossRef Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA 1997; 277(4): 307–11PubMedCrossRef
8.
Zurück zum Zitat Conroy S. Paediatric pharmacy: drug therapy. Hosp Pharm 2003; 10: 49–50, 54, 56-7 Conroy S. Paediatric pharmacy: drug therapy. Hosp Pharm 2003; 10: 49–50, 54, 56-7
9.
Zurück zum Zitat Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80(2): F142–4PubMedCrossRef Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80(2): F142–4PubMedCrossRef
10.
Zurück zum Zitat Koren G. Therapeutic drug monitoring principles in the neonate. National Academy of Clinical Biochemistry. Clin Chem 1997; 43(1): 222–7PubMed Koren G. Therapeutic drug monitoring principles in the neonate. National Academy of Clinical Biochemistry. Clin Chem 1997; 43(1): 222–7PubMed
11.
Zurück zum Zitat Zeroing in on medication errors. Lancet 1997; 349 (9049): 369 Zeroing in on medication errors. Lancet 1997; 349 (9049): 369
12.
Zurück zum Zitat Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285(16): 2114–20PubMedCrossRef Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285(16): 2114–20PubMedCrossRef
13.
Zurück zum Zitat Vincer MJ, Murray JM, Yuill A, et al. Drug errors and incidents in a neonatal intensive care unit: a quality assurance activity. Am J Dis Child 1989; 143(6): 737–40PubMed Vincer MJ, Murray JM, Yuill A, et al. Drug errors and incidents in a neonatal intensive care unit: a quality assurance activity. Am J Dis Child 1989; 143(6): 737–40PubMed
14.
Zurück zum Zitat Williams E, Talley R. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm 1994; 29(4): 331–2PubMed Williams E, Talley R. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm 1994; 29(4): 331–2PubMed
15.
Zurück zum Zitat Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994; 29(4): 319–30PubMed Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994; 29(4): 319–30PubMed
16.
Zurück zum Zitat Schneider PJ. Applying human factors in improving medication-use safety. Am J Health Syst Pharm 2002; 59(12): 1155–9PubMed Schneider PJ. Applying human factors in improving medication-use safety. Am J Health Syst Pharm 2002; 59(12): 1155–9PubMed
17.
Zurück zum Zitat Raju TN, Kecskes S, Thornton JP, et al. Medication errors in neonatal and paediatric intensive-care units. Lancet 1989; II(8659): 374–6CrossRef Raju TN, Kecskes S, Thornton JP, et al. Medication errors in neonatal and paediatric intensive-care units. Lancet 1989; II(8659): 374–6CrossRef
18.
Zurück zum Zitat Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29–34PubMedCrossRef Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29–34PubMedCrossRef
19.
Zurück zum Zitat Spath PL. Using failure mode and effects analysis to improve patient safety. AORN J 2003; 78(1): 16–37PubMedCrossRef Spath PL. Using failure mode and effects analysis to improve patient safety. AORN J 2003; 78(1): 16–37PubMedCrossRef
20.
Zurück zum Zitat Perlstein PH, Callison C, White M, et al. Errors in drug computations during newborn intensive care. Am J Dis Child 1979; 133(4): 376–9PubMed Perlstein PH, Callison C, White M, et al. Errors in drug computations during newborn intensive care. Am J Dis Child 1979; 133(4): 376–9PubMed
21.
Zurück zum Zitat Pepper GA. Errors in drug administration by nurses. Am J Health Syst Pharm 1995; 52(4): 390–5PubMed Pepper GA. Errors in drug administration by nurses. Am J Health Syst Pharm 1995; 52(4): 390–5PubMed
22.
Zurück zum Zitat Fontan JE, Maneglier V, Nguyen VX, et al. Medication errors in hospitals: computerized unit dose drug dispensing system versus ward stock distribution system. Pharm World Sci 2003; 25(3): 112–7PubMedCrossRef Fontan JE, Maneglier V, Nguyen VX, et al. Medication errors in hospitals: computerized unit dose drug dispensing system versus ward stock distribution system. Pharm World Sci 2003; 25(3): 112–7PubMedCrossRef
23.
Zurück zum Zitat Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003; 111(4 Pt 1): 722–9PubMedCrossRef Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics 2003; 111(4 Pt 1): 722–9PubMedCrossRef
24.
Zurück zum Zitat Cousins D, Clarkson A, Conroy S, et al. Medication errors in children: an eight year review using press reports. Paediatr Perinat Drug Ther 2002; 5(2): 52–8CrossRef Cousins D, Clarkson A, Conroy S, et al. Medication errors in children: an eight year review using press reports. Paediatr Perinat Drug Ther 2002; 5(2): 52–8CrossRef
25.
Zurück zum Zitat Wilson DG, McArtney RG, Newcombe RG, et al. Medication errors in paediatric practice: insights from a continuous quality improvement approach. Eur J Pediatr 1998 Sep; 157(9): 769–74PubMedCrossRef Wilson DG, McArtney RG, Newcombe RG, et al. Medication errors in paediatric practice: insights from a continuous quality improvement approach. Eur J Pediatr 1998 Sep; 157(9): 769–74PubMedCrossRef
26.
Zurück zum Zitat Folli HL, Poole RL, Benitz WE, et al. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 1987; 79(5): 718–22PubMed Folli HL, Poole RL, Benitz WE, et al. Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 1987; 79(5): 718–22PubMed
27.
Zurück zum Zitat Kozer E, Scolnik D, Macpherson A, et al. Variables associated with medication errors in pediatric emergency medicine. Pediatrics 2002; 110(4): 737–42PubMedCrossRef Kozer E, Scolnik D, Macpherson A, et al. Variables associated with medication errors in pediatric emergency medicine. Pediatrics 2002; 110(4): 737–42PubMedCrossRef
28.
Zurück zum Zitat Lesar TS, Briceland LL, Delcoure K, et al. Medication prescribing errors in a teaching hospital. JAMA 1990; 263(17): 2329–34PubMedCrossRef Lesar TS, Briceland LL, Delcoure K, et al. Medication prescribing errors in a teaching hospital. JAMA 1990; 263(17): 2329–34PubMedCrossRef
29.
Zurück zum Zitat Ross LM, Wallace J, Paton JY, et al. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000; 83(6): 492–7PubMedCrossRef Ross LM, Wallace J, Paton JY, et al. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000; 83(6): 492–7PubMedCrossRef
30.
Zurück zum Zitat Vincent C, Taylor-Adams S, Stanhope N. Framework for analysing risk and safety in clinical medicine. BMJ 1998; 316(7138): 1154–7PubMedCrossRef Vincent C, Taylor-Adams S, Stanhope N. Framework for analysing risk and safety in clinical medicine. BMJ 1998; 316(7138): 1154–7PubMedCrossRef
31.
Zurück zum Zitat Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274(1): 35–43PubMedCrossRef Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274(1): 35–43PubMedCrossRef
32.
Zurück zum Zitat Runciman WB, Edmonds MJ, Pradhan M. Setting priorities for patient safety. Qual Saf Health Care 2002; 11(3): 224–9PubMedCrossRef Runciman WB, Edmonds MJ, Pradhan M. Setting priorities for patient safety. Qual Saf Health Care 2002; 11(3): 224–9PubMedCrossRef
33.
Zurück zum Zitat Marx DA, Slonim AD. Assessing patient safety risk before the injury occurs: an introduction to sociotechnical probabilistic risk modelling in health care. Qual Saf Health Care 2003; 12Suppl. 2: II33–8PubMed Marx DA, Slonim AD. Assessing patient safety risk before the injury occurs: an introduction to sociotechnical probabilistic risk modelling in health care. Qual Saf Health Care 2003; 12Suppl. 2: II33–8PubMed
Metadaten
Titel
Identification of Priorities for Medication Safety in Neonatal Intensive Care
verfasst von
Desireé L. Kunac
David M. Reith
Publikationsdatum
01.03.2005
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 3/2005
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200528030-00006

Weitere Artikel der Ausgabe 3/2005

Drug Safety 3/2005 Zur Ausgabe

Original Research Article

Tibolone and Endometrial Cancer